NovoCure Ltd — Director's Dealing 2018

Aug 16, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-08-14

Reporting Person: GROENHUYSEN WILHELMUS CM (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-14	Ordinary Shares	S	100	$37.85	Disposed	108118	Direct
2018-08-14	Ordinary Shares	S	400	$37.90	Disposed	107718	Direct
2018-08-14	Ordinary Shares	S	200	$38.00	Disposed	107518	Direct
2018-08-14	Ordinary Shares	S	68	$37.80	Disposed	107450	Direct
2018-08-14	Ordinary Shares	S	200	$37.70	Disposed	107250	Direct
2018-08-14	Ordinary Shares	S	500	$37.75	Disposed	106750	Direct
2018-08-14	Ordinary Shares	S	200	$37.55	Disposed	106550	Direct
2018-08-14	Ordinary Shares	S	300	$37.65	Disposed	106250	Direct
2018-08-14	Ordinary Shares	S	100	$37.60	Disposed	106150	Direct
2018-08-14	Ordinary Shares	S	2300	$37.50	Disposed	103850	Direct

Footnotes

F1: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Groenhuysen.